Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-03 00:57 | 2020-11-30 | AAT | American Assets Trust, Inc. | RADY ERNEST S | Director, Officer, 10% owner - Chairman, CEO & President | Real Estate Investment Trusts | BUY | $28.99 | 50,089 | $1,452,130 | 1,673,449 | +3.1% |
| 2020-12-02 17:44 | 2020-12-01 | ESP | ESPEY MFG & ELECTRONICS CORP | PINSLEY HOWARD M | Director, 10% owner | Electronic Components, NEC | BUY | $18.29 | 300,000 | $5,487,000 | 300,000 | +100.0% |
| 2020-12-02 17:47 | 2020-12-01 | ESP | ESPEY MFG & ELECTRONICS CORP | MURPHY PEGGY A | Officer, 10% owner - Corporate Secretary | Electronic Components, NEC | BUY | $18.29 | 300,000 | $5,487,000 | 300,000 | +100.0% |
| 2020-12-03 01:32 | 2020-11-30 | CMT | CORE MOLDING TECHNOLOGIES INC | ANDERSON RENEE R | Officer - EVP, Human Resources | Plastics Products, NEC | BUY | $4,400.00 | 400 | $1,760,000 | 70,542 | +0.6% |
| 2020-12-02 02:28 | 2020-11-27 | FL | N/A | Vesa Equity Investment S.a r.l. | 10% owner | Other | BUY | $38.16 | 342,840 | $13,082,774 | 11,573,977 | +3.1% |
| 2020-12-01 21:59 | 2020-11-30 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $22.05 | 737,739 | $16,265,010 | 21,917,237 | +3.5% |
| 2020-12-01 21:36 | 2020-11-30 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $22.05 | 1,144,300 | $25,228,492 | 33,995,604 | +3.5% |
| 2020-12-02 01:20 | 2020-11-30 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $20.06 | 169,503 | $3,399,997 | 1,175,903 | +16.8% |
| 2020-12-02 00:57 | 2020-11-30 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $20.06 | 575,812 | $11,549,990 | 3,994,612 | +16.8% |
| 2020-12-02 00:30 | 2020-11-30 | N-A | N/A | Manulife Life Insurance Co | 10% owner | Other | BUY | $20.06 | 132,113 | $2,649,998 | 916,513 | +16.8% |
| 2020-12-02 00:10 | 2020-11-30 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $20.06 | 368,919 | $7,399,994 | 2,559,319 | +16.8% |
| 2020-12-02 04:03 | 2020-11-27 | GNPK | Redwire Corp | Genesis Park II LP | Director, 10% owner | Guided Missiles & Space Vehicles & Parts | BUY | $10.00 | 1,000,000 | $10,000,000 | 1,000,000 | +100.0% |
| 2020-12-02 00:32 | 2020-11-27 | SREV | N/A | Edenbrook Capital, LLC | 10% owner | Other | BUY | $1.30 | 4,706,139 | $6,117,981 | 18,317,265 | +34.6% |
| 2020-12-02 03:56 | 2020-11-27 | GNPK | Redwire Corp | HOBBY PAUL W | Director, Officer - Chief Executive Officer | Guided Missiles & Space Vehicles & Parts | BUY | $10.00 | 100,000 | $1,000,000 | 100,000 | +100.0% |
| 2020-12-01 00:09 | 2020-11-01 | N-A | N/A | Partners Group Private Equity II, LLC | Other | Other | BUY | $6.47 | 1,544,425 | $10,000,000 | 10,657,269 | +16.9% |
| 2020-11-28 01:46 | 2020-11-24 | FL | N/A | Vesa Equity Investment S.a r.l. | 10% owner | Other | BUY | $38.65 | 509,575 | $19,696,755 | 11,231,137 | +4.8% |
| 2020-11-27 22:40 | 2020-11-24 | CAS-U | N/A | Levine Jay N. | Director, Officer, 10% owner - Chief Executive Officer | Other | BUY | $10.00 | 250,000 | $2,500,000 | 250,000 | +100.0% |
| 2020-11-28 01:23 | 2020-11-24 | BLFS | BIOLIFE SOLUTIONS INC | Casdin Partners Master Fund, L.P. | 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $22.50 | 1,600,000 | $36,000,000 | 7,440,107 | +27.4% |
| 2020-11-26 03:52 | 2020-11-24 | MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Hopfield Jessica | Director | Pharmaceutical Preparations | BUY | $27.00 | 50,000 | $1,350,000 | 61,852 | +421.9% |
| 2020-11-25 20:21 | 2020-11-19 | GTX-GTXMQ | Garrett Motion Inc. | Attestor Value Master Fund, LP | Other | Motor Vehicle Parts & Accessories | BUY | $4.37 | 486,000 | $2,122,799 | 3,147,970 | +18.3% |
| 2020-11-26 01:01 | 2020-11-24 | STOK | Stoke Therapeutics, Inc. | Apple Tree Partners IV, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $39.00 | 375,000 | $14,625,000 | 17,161,713 | +2.2% |
| 2020-11-26 01:03 | 2020-11-24 | STOK | Stoke Therapeutics, Inc. | Harrison Seth Loring | Director, 10% owner | Pharmaceutical Preparations | BUY | $39.00 | 375,000 | $14,625,000 | 17,161,713 | +2.2% |
| 2020-11-24 23:32 | 2020-11-19 | TLS | TELOS CORP | Schaufeld Fredrick | Director | Services-Computer Integrated Systems Design | BUY | $4,342,633.00 | 255,449 | $1,109,321,257,217 | 255,449 | +100.0% |
| 2020-11-24 23:29 | 2020-03-13 | FCNCA | FIRST CITIZENS BANCSHARES INC /DE/ | Holding Olivia Britton | 10% owner | State Commercial Banks | BUY | $20.82 | 118,945 | $2,476,482 | 198,945 | +148.7% |
| 2020-11-25 05:06 | 2020-11-20 | FTSI | N/A | THRC Holdings, LP | 10% owner | Other | BUY | $15.33 | 876,280 | $13,435,475 | 2,750,000 | +46.8% |
| 2020-11-25 05:56 | 2020-11-20 | FTSI | N/A | THRC Holdings, LP | 10% owner | Other | BUY | $15.51 | 776,280 | $12,037,929 | 2,750,000 | +39.3% |
| 2020-11-25 00:15 | 2020-11-20 | LAZY | N/A | Coliseum Capital Management, LLC | Director, 10% owner | Other | BUY | $13.44 | 111,348 | $1,496,517 | 721,362 | +18.3% |
| 2020-11-25 02:49 | 2020-11-20 | BH | Biglari Holdings Inc. | BIGLARI, SARDAR | Director, Officer, 10% owner - Chairman and CEO | Retail-Eating Places | BUY | $109.67 | 23,613 | $2,589,522 | 792,677 | +3.1% |
| 2020-11-25 00:45 | 2020-11-24 | VTVT | vTv Therapeutics Inc. | PERELMAN RONALD O | 10% owner | Pharmaceutical Preparations | BUY | $1.60 | 625,000 | $1,000,000 | 35,356,212 | +1.8% |
| 2020-11-24 16:00 | 2020-11-23 | MGTX | MeiraGTx Holdings plc | PERCEPTIVE ADVISORS LLC | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $12.85 | 500,000 | $6,425,000 | 6,933,277 | +7.8% |
| 2020-11-25 00:09 | 2020-11-20 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $108.00 | 1,527,777 | $164,999,916 | 12,736,556 | +13.6% |
| 2020-11-24 23:16 | 2020-03-13 | FCNCA | FIRST CITIZENS BANCSHARES INC /DE/ | BRYANT HOPE HOLDING | Director, Officer, 10% owner - Vice Chairman | State Commercial Banks | BUY | $20.82 | 118,945 | $2,476,482 | 198,945 | +148.7% |
| 2020-11-24 05:54 | 2020-11-19 | TLS | TELOS CORP | Schaufeld Fredrick | Director | Services-Computer Integrated Systems Design | BUY | $4,463,044.00 | 262,532 | $1,171,691,867,408 | 262,532 | +100.0% |
| 2020-11-24 05:17 | 2020-11-19 | TLS | TELOS CORP | Carroll Bonnie Lynn | Director | Services-Computer Integrated Systems Design | BUY | $9,996.00 | 588 | $5,877,648 | 588 | +100.0% |
| 2020-11-24 01:30 | 2020-11-19 | PAND | N/A | Becker Daniel J. | Director | Other | BUY | $15.12 | 197,716 | $2,989,466 | 2,827,883 | +7.5% |
| 2020-11-24 00:35 | 2020-11-23 | OLMA | Olema Pharmaceuticals, Inc. | Graham G. Walmsley | Director | Pharmaceutical Preparations | BUY | $19.00 | 1,160,000 | $22,040,000 | 1,160,000 | +100.0% |
| 2020-11-24 05:47 | 2020-11-19 | PRTY | N/A | SOSIN CLIFFORD | 10% owner | Other | BUY | $4.00 | 1,600,000 | $6,399,840 | 15,263,623 | +11.7% |
| 2020-11-24 00:59 | 2020-11-23 | OLMA | Olema Pharmaceuticals, Inc. | Cormorant Asset Management, LP | Other | Pharmaceutical Preparations | BUY | $19.00 | 425,000 | $8,075,000 | 3,270,544 | +14.9% |
| 2020-11-23 16:42 | 2020-11-19 | TLS | TELOS CORP | Maluda John W | Director | Services-Computer Integrated Systems Design | BUY | $7,497.00 | 441 | $3,306,177 | 63,930 | +0.7% |
| 2020-11-23 20:58 | 2020-11-19 | VTA | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $9.94 | 375,259 | $3,730,375 | 8,451,755 | +4.6% |
| 2020-11-24 02:33 | 2020-11-20 | COTY | COTY INC. | HUTH JOHANNES P | Director | Perfumes, Cosmetics & Other Toilet Preparations | BUY | $6.20 | 1,000,000 | $6,199,000 | 1,000,000 | +100.0% |
| 2020-11-24 03:41 | 2020-11-19 | DHR | DANAHER CORP /DE/ | RALES MITCHELL P | Director, Officer - Chairman of Exec. Committee | Industrial Instruments For Measurement, Display, and Control | BUY | $226.14 | 26,784 | $6,056,934 | 2,404,658 | +1.1% |
| 2020-11-21 02:44 | 2020-11-18 | CAR | AVIS BUDGET GROUP, INC. | SRS Investment Management, LLC | Director, 10% owner | Services-Auto Rental & Leasing (No Drivers) | BUY | $35.09 | 104,900 | $3,681,319 | 18,303,324 | +0.6% |
| 2020-11-21 04:07 | 2020-11-18 | PMFLX | PIMCO Flexible Municipal Income Fund | Roman Emmanuel | Other | Other | BUY | $11.16 | 268,817 | $2,999,998 | 268,817 | +100.0% |
| 2020-11-21 03:46 | 2020-11-18 | PLXP | N/A | Valentino Michael J | Director, Officer - Executive Chairman | Other | BUY | $3.79 | 264,900 | $1,003,176 | 461,690 | +134.6% |
| 2020-11-21 04:02 | 2020-11-19 | OLMA | Olema Pharmaceuticals, Inc. | BVF PARTNERS L P/IL | Director, 10% owner | Pharmaceutical Preparations | BUY | $19.00 | 1,135,334 | $21,571,346 | 436,082 | +100.0% |
| 2020-11-21 03:51 | 2020-11-16 | SRT | N/A | Sharda Mukesh | Director | Other | BUY | $7.02 | 206,814 | $1,451,834 | 206,814 | +100.0% |
| 2020-11-21 03:49 | 2020-11-16 | SRT | N/A | Rao Bharat | Director | Other | BUY | $7.02 | 206,814 | $1,451,834 | 206,814 | +100.0% |
| 2020-11-20 00:38 | 2020-11-17 | KROS | Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $50.00 | 60,000 | $3,000,000 | 155,262 | +63.0% |
| 2020-11-20 00:40 | 2020-11-17 | KROS | Keros Therapeutics, Inc. | Nussbaum Ran | Director, 10% owner | Pharmaceutical Preparations | BUY | $50.00 | 60,000 | $3,000,000 | 155,262 | +63.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.